Análisis Argos
A
ACara
Agilent Technologies, Inc. · Healthcare
US$ 130.69
precio al 2026-07-04
Valor justo Argos*
US$ 75–92
vs. su valor justo
56% por encima
Score Argos
48/100
LA RESPUESTA
El mercado le pide crezca 18.7% al año — más de lo que ha demostrado (7.8%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Retorno sobre el capital alto (16%).
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
VALOR2/6FUTURO3/6PASADO4/6SALUD4/6DIVIDENDO3/6
El Iris de calidad
VALOR2/6FUTURO3/6PASADO4/6SALUD4/6DIVIDENDO3/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance fuerte, deuda controlada
DividendoRetorno al accionista moderado
Score Argos48de 100Cara
Ingresos7%
US$ 7 B
Margen operativo7%
21.3%
Flujo de caja libre16%
US$ 1.2 B
Deuda neta
US$ 1.6 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 36.9B
P/E28.3x
EV/EBITDA21.8x
FCF yield3.1%
ROIC16.2%
Margen operativo21.3%
Crecim. ingresos+6.7%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 26 jun
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
globenewswire.com · 25 jun
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical ("Biocare"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. ("Agilent", NYSE:A).
businesswire.com · 25 jun
Agilent Completes Acquisition of Biocare Medical
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent's Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st.
seekingalpha.com · 24 jun
Canadian Apartment REIT: A 4.5% Dividend Yield With Ample Coverage
Canadian Apartment Properties REIT trades at 15x AFFO and nearly 40% below NAV, offering compelling value. Q1 AFFO per share declined just 1.5% to C$0.513, with a strong 70% payout ratio and robust distribution coverage. Active buybacks and retained AFFO (~C$100 million/year) support growth initiatives and the development pipeline.
prnewswire.com · 24 jun
Lost Money on Zoetis Inc. (ZTS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Alert: Claims Focus on Alleged Misrepresentations About Weakening Veterinarian Adoption and Prescription Trends That Cost ZTS Investors $23.91 Per Share Following the Final Disclosure NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Zoetis Inc. (NYSE: ZTS) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026.
prnewswire.com · 24 jun
Lost Money on Verra Mobility Corporation (VRRM)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Alert: Claims Focus on Alleged Misrepresentations About the Durability of Verra Mobility's Largest Customer Contract and the $35 Million Revenue Hole Left by Avis Budget Group's Termination NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Verra Mobility Corporation (NASDAQ: VRRM) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased VRRM securities between February 24, 2026 and May 26, 2026.
prnewswire.com · 24 jun
GPK Deadline Alert: Levi & Korsinsky Reminds Graphic Packaging Holding Company (GPK) Investors of Securities Class Action Deadline on July 6, 2026
Alert: Claims Focus on Alleged Inventory Mismanagement and Production Curtailments That Drove $130 Million in Projected 2026 EBITDA Losses NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Graphic Packaging Holding Company (NYSE: GPK) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased GPK securities between February 4, 2025 and February 2, 2026.
globenewswire.com · 24 jun
UMH PROPERTIES, INC. WELCOMES THE 21ST CENTURY ROAD TO HOUSING ACT: A MAJOR BOOST FOR AFFORDABLE MANUFACTURED HOUSING
Freehold, NJ, June 24, 2026 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, today expressed strong support for the 21st Century ROAD to Housing Act, comprehensive bipartisan legislation designed to address the nation's housing shortage by expanding supply, reducing costs, and modernizing regulations for manufactured housing.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.